Melanoma evolves complete immunotherapy resistance through the acquisition of a hypermetabolic phenotype

AR Jaiswal, AJ Liu, S Pudakalakatti, P Dutta… - Cancer immunology …, 2020 - AACR
Despite the clinical success of T-cell checkpoint blockade, most patients with cancer still fail
to have durable responses to immunotherapy. The molecular mechanisms driving …
被引用次数：45 相关文章

Melanoma evolves complete immunotherapy resistance through the acquisition of a hypermetabolic phenotype

AR Jaiswal, AJ Liu… - Cancer …, 2020 - mdanderson.elsevierpure.com
Despite the clinical success of T-cell checkpoint blockade, most patients with cancer still fail
to have durable responses to immunotherapy. The molecular mechanisms driving …
[HTML] nih.gov

[HTML][HTML] Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype

AR Jaiswal, AJ Liu, S Pudakalakatti… - Cancer immunology …, 2020 - ncbi.nlm.nih.gov
Despite the clinical success of T cell checkpoint blockade, most cancer patients still fail to
have durable responses to immunotherapy. The molecular mechanisms driving checkpoint …

Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype

AR Jaiswal, AJ Liu, S Pudakalakatti… - Cancer …, 2020 - pubmed.ncbi.nlm.nih.gov
Despite the clinical success of T-cell checkpoint blockade, most patients with cancer still fail
to have durable responses to immunotherapy. The molecular mechanisms driving …

Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype.

AR Jaiswal, AJ Liu, S Pudakalakatti, P Dutta… - Cancer Immunology …, 2020 - europepmc.org
Despite the clinical success of T cell checkpoint blockade, most cancer patients still fail to
have durable responses to immunotherapy. The molecular mechanisms driving checkpoint …